Company: NKLR
Filing Date: 2025-12-16
Form Type: 424B3
Source: 0001213900-25-121900
Chunk: 241

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-16
Form: 424B3
Chunk 241
---
-cooled design, multiple safety shutdown mechanisms, safeguard-by-design, small footprint,
and the ability to use commercially available Low Enriched Uranium (“LEU”), which significantly reduces regulatory and technological
barriers typical in nuclear energy development. Terra has made substantial progress in de-risking its First-of-a-Kind (“FOAK”)
reactor, including initiating regulatory engagement with the U.S. Nuclear Regulatory Commission (“NRC”), and establishing
a robust supply chain strategy. Terra has completed the reactor design, validated key technological components, and is advancing through
critical regulatory milestones to achieve Terra’s 2027 FOAK reactor completion target.

Note 2. Going Concern

As of December 31, 2024, the Company had
cash of $68,934. For the year ended December 31, 2024, the Company used approximately $41,192 in cash for operating activities.
Historically, the Company has incurred recurring net losses from operations and negative cash flows from operating activities. As of
December 31, 2024, the Company had an accumulated deficit of approximately $36,862.

These factors raise substantial doubt regarding
the Company’s ability to continue as a going concern within one year of the date these financial statements were issued.

The Company is trying to alleviate the going
concern risk through the debt and equity financing in the United States (“U.S.”) capital market to support its
working capital after the Merger (refer to Note 12. Subsequent Events). However, there is no guarantee that the substantial doubt
about the Company’s ability to continue as a going concern will be alleviated. The ability of the Company to continue as a going
concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and
its ability to raise additional funds.

These accompanying financial statements have
been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the
outcome of this uncertainty.

Note 3. Summary of Significant Accounting Policies

The accompanying financial statements have been
prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Cash and Cash Equivalents

The Company considers all highly liquid investments
with original maturities of three months or less at the time of purchase to be cash equivalents. Cash equivalents are stated at
cost, which approximates market value, because of the short maturity of these instruments. The Company had $68,934 and